Genetic Engineering Publications - GEG Tech top picks

In this work, the scientists assess the capacity of intra-arterial delivered autologous engineered canine CD133+ cells of restoring dystrophin expression in golden Retriever dystrophic dogs (GRMD) . This is the first demonstration of five-year follow up study, showing initial clinical amelioration followed by stabilization in mild and severe affected GRMD dogs. The occurrence of T-cell response in three GRMD dogs, consistent with a memory response boosted by the exon skipped-dystrophin protein, suggests an adaptive immune response against dystrophin.